BioWorld

Nov. 27, 2002

Pathogenic Genomics Project Funded By Genome Canada

Genome Canada's deep pockets and ambitious genomics plans are trickling down to the lower levels where the actual work will be done. (Bioworld Today) Read More

Surface Logix Completes $25M Round For Drug Discovery Work

Gains European Approval Of Zavesca For Gaucher's Disease

IDDS, eXegenics Merger Falls Through; Reason Not Disclosed

Other News To Note

Holiday Notice

Today's news in brief

BioWorld

BioWorld briefs for Dec. 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 11, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Illustration of head with maze that is missing parts

CTAD 2025: The challenges of combination therapies for dementia

BioWorld Science

At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...

DEE-lightful: Praxis’ phase II results allow stock to flex its muscle

BioWorld

Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...